BrioHealth Solutions Announces FDA Conditional Approval of Pediatric BrioVAD System Study-The Brio4Kids Trial
BURLINGTON, Mass., April 24, 2026 /PRNewswire/ -- BrioHealth Solutions (www.briohealthsolutions.com) announced that it has received FDA conditional approval to initiate a clinical evaluation of the BrioVAD® System in pediatric patients with advanced heart failure. The Brio4Kids Trial will...
View original →